A program designed to conduct drug development clinical trials for a psychedelic drug in Texas hit a road bump after the ...
The Texas Tribune on MSN
Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help
The Legislature last year approved $50 million to research the psychedelic and find a company to develop it into a drug for ...
10don MSN
Over the past decade, early-stage drug innovation has shifted toward China, researchers find
Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a ...
The adoption of AI in clinical trials holds the potential to revolutionize how therapies are discovered, but the pace of that ...
The State of Texas will launch its own program to research a psychoactive drug called ibogaine after it was unable to find a ...
The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop ...
Announcing a new article publication for BIO Integration journal. Clinical trials bridge basic research and clinical application, serving as essential steps in drug development. This review examines ...
In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...
HSSA Funding to Support Commercialization of Biological Testing Platform and High-Paying Bioscience Jobs in Spokane ...
StockStory.org on MSN
Reflecting on drug development inputs & services stocks’ Q4 earnings: IQVIA (NYSE:IQV)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results